Cargando…
Chemotherapy-induced peripheral neuropathy: part 1—current state of knowledge and perspectives for pharmacotherapy
BACKGROUND: Despite the increasing knowledge of the etiology of neuropathic pain, this type of chronic pain is resistant to available analgesics in approximately 50% of patients and therefore is continuously a subject of considerable interest for physiologists, neurologists, medicinal chemists, phar...
Autor principal: | Sałat, Kinga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329796/ https://www.ncbi.nlm.nih.gov/pubmed/32394362 http://dx.doi.org/10.1007/s43440-020-00109-y |
Ejemplares similares
-
Chemotherapy-induced peripheral neuropathy—part 2: focus on the prevention of oxaliplatin-induced neurotoxicity
por: Sałat, Kinga
Publicado: (2020) -
Ozone in Chemotherapy-Induced Peripheral Neuropathy—Current State of Art, Possibilities, and Perspectives
por: Szklener, Katarzyna, et al.
Publicado: (2023) -
Chemotherapy-induced peripheral neuropathy. Part II. Prevention
por: Brzeziński, Krzysztof
Publicado: (2012) -
Chemotherapy-induced peripheral neuropathy: an update on the current understanding
por: Addington, James, et al.
Publicado: (2016) -
Insights into platinum-induced peripheral neuropathy–current perspective
por: Lazić, Andrijana, et al.
Publicado: (2020)